Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 140 participants.
Also called NCT02845531
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Registry
-
NCT02845531
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT02845531. Randomized; no masking; primary purpose treatment. Start 2016-11-29 (actual); primary completion 2030-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
- Acronym
- VARIANT ICD
- Condition
- Angina Pectoris, Variant
- Condition
- Sudden Cardiac Death
- Intervention (Device)
- Implantable Cardioverter Defibrillator
- Intervention (Drug)
- Optimal Medical Therapy
- Lead sponsor
- Kee-joon Choi
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct02845531- Content hash
5a5faf7e0580c49cc1be45f1cc79c55977a2a83f0e9ddc4e1a14d1b78630e72c